EX-1.1 OTHERDOC 2 0002.txt JOINT FILING AGREEMENTJoint Filing Agreement • June 14th, 2002 • Pharmacopeia Inc • Services-commercial physical & biological research
The undersigned hereby agree that the Statement on this Schedule 13G, dated June 12, 2002, (the "Schedule 13G"), with respect to the Common Stock, no par value per share, of Pharmacopeia, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
TABLE OF CONTENTSPharmacopeia Inc • December 14th, 2001 • Services-commercial physical & biological research • California
AND PHARMACOPEIA, INC. (3) --------------------------- AGREEMENT FOR THE SALE AND PURCHASE OF THE ENTIRE ISSUED SHARE CAPITAL OF OXFORD MOLECULAR LIMITED AND CHEMICAL DESIGN HOLDINGS PLC AND ALL THE OUTSTANDING STOCK OF OXFORD MOLECULAR GROUP, INC....Agreement • August 16th, 2000 • Pharmacopeia Inc • Services-commercial physical & biological research • England and Wales
AGREEMENT This agreement ("Agreement") is effective as of March 30, 2001 ("Effective Date") between Affymetrix, Inc. ("Affymetrix") a Delaware corporation having its principal place of business at 3380 Central Expressway, Santa Clara, California...Supply Agreement • December 3rd, 2001 • Pharmacopeia Inc • Services-commercial physical & biological research • California
Exhibit 10.53 STOCK PURCHASE AGREEMENT Pharmacopeia, Inc. CN 5350 Princeton, NJ 08543-5340 The undersigned (the "Investor"), hereby confirms its agreement with you as follows: 1. This Stock Purchase Agreement (the "Agreement") is made as of the date...Stock Purchase Agreement • May 15th, 2000 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
AGREEMENT ---------Separation Agreement • October 11th, 2005 • Accelrys, Inc. • Services-prepackaged software • California
RECITALSIndemnity Agreement • March 29th, 1999 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
Exhibit 10.27 CONSULTING AGREEMENT FOR FOUNDING MEMBERS OF THE PHARMACOPEIA, INC. SCIENTIFIC ADVISORY BOARD This Agreement is made as of March ___, 1993, between PharmaCopeia, Inc. (the "Company") and Paul A. Bartlett (the "Consultant") and shall be...Consulting Agreement • March 27th, 2001 • Pharmacopeia Inc • Services-commercial physical & biological research • California
Exhibit 2 DATED JUNE 21, 2001 ------------------- AGREEMENT FOR THE SALE AND PURCHASE OF SHARES IN SYNOMICS LIMITEDPharmacopeia Inc • July 13th, 2001 • Services-commercial physical & biological research
EXHIBIT 10.35 JOINT VENTURE AGREEMENT February 14, 1992Joint Venture Agreement • August 14th, 1998 • Pharmacopeia Inc • Services-commercial physical & biological research
TABLE OF CONTENTSPharmacopeia Inc • October 2nd, 2001 • Services-commercial physical & biological research • California
EXHIBIT 4.1 STOCK PURCHASE AGREEMENT Pharmacopeia, Inc. CN 5350 Princeton, NJ 08543-5340 The undersigned (the "Investor"), hereby confirms its agreement with you as follows: 1. This Stock Purchase Agreement (the "Agreement") is made as of the date set...Stock Purchase Agreement • April 11th, 2000 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
WITNESSETHCollaboration Agreement • December 14th, 2001 • Pharmacopeia Inc • Services-commercial physical & biological research • Washington
EXHIBIT 10.49 LEASE PARTIESPharmacopeia Inc • August 4th, 1999 • Services-commercial physical & biological research
EXHIBIT 10.26 CONSULTING AGREEMENT This CONSULTING AGREEMENT, made the 12th day of December 2000 is between PHARMACOPEIA INC. ("PCOP"), a Delaware corporation having a place of business at 3000 Eastpark Blvd., Cranbury, NJ 08512 and RICHARD WALSH...Consulting Agreement • March 27th, 2001 • Pharmacopeia Inc • Services-commercial physical & biological research • New Jersey
Amendment No. 3 to Research, License and Royalty Agreement ---------------------------------------------------------- This Amendment No. 3 to Research, License and Royalty Agreement (the "Amendment") effective as of November 21, 1997, is entered into...Royalty Agreement • March 2nd, 1998 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
Exhibit 10.43 COLLABORATION AND LICENSE AGREEMENT By and Among PHARMACOPEIA, INC.Collaboration and License Agreement • March 29th, 1999 • Pharmacopeia Inc • Services-commercial physical & biological research • New Jersey
GUARANTEEGuarantee • March 29th, 1999 • Pharmacopeia Inc • Services-commercial physical & biological research • New Jersey
EXHIBIT 10.40 AMENDED AND RESTATED DISTRIBUTORSHIP AGREEMENT March 1, 1998Distributorship Agreement • November 13th, 1998 • Pharmacopeia Inc • Services-commercial physical & biological research • California
INDEMNIFICATION AGREEMENTIndemnification Agreement • March 7th, 2013 • Accelrys, Inc. • Services-prepackaged software • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of March _______, 2013, by and among ACCELRYS, INC., a Delaware corporation (the “Company”) and _____________ (the “Indemnitee”).
December 16, 1997 Dr. Joseph A. Mollica 101 College Road East Princeton Forrestal Center Princeton, NJ 08540 Dear Joe: As you know, the letter agreement between you and Pharmacopeia, Inc. (the "Company") dated January 12, 1994 (the "1994 Letter")...Pharmacopeia Inc • March 2nd, 1998 • Services-commercial physical & biological research • New Jersey
AGREEMENT AND PLAN OF MERGER Dated as of January 30, 2014, Among DASSAULT SYSTEMES AMERICAS CORP., 3DS ACQUISITION CORP. And ACCELRYS, INC.Agreement and Plan of Merger • January 30th, 2014 • Accelrys, Inc. • Services-prepackaged software • Delaware
AGREEMENT AND PLAN OF MERGER (“Agreement”) dated as of January 30, 2014, among DASSAULT SYSTEMES AMERICAS CORP., a Delaware corporation (“Parent”), 3DS ACQUISITION CORP., a Delaware corporation (“Sub”) and a wholly owned subsidiary of Parent, and ACCELRYS, INC., a Delaware corporation (the “Company”).
AMENDMENT NO. 1 TO RESEARCH, LICENSE AND ROYALTY AGREEMENT This Amendment No. 1 to Research, License and Royalty Agreement (the "Amendment") effective as of November 27, 1996, is entered into by and between Pharmacopeia, Inc. ("Pharmacopeia") and...License and Royalty Agreement • August 13th, 1997 • Pharmacopeia Inc • Services-commercial physical & biological research • Delaware
EXHIBIT 10.41 INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (the "Agreement") is made as of March 1, 1998 (the "Effective Date"), by and between MOLECULAR SIMULATIONS INCORPORATED, a Delaware corporation ("MSI"), and TEIJIN MOLECULAR SIMULATIONS...Indemnity Agreement • November 13th, 1998 • Pharmacopeia Inc • Services-commercial physical & biological research • California
Exhibit 1.1 ----------- JOINT FILING AGREEMENT The undersigned hereby agree that the Statement on this Schedule 13G/A, dated February 14, 2003, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.0001 per share, of Pharmacopeia,...Joint Filing Agreement • February 14th, 2003 • Pharmacopeia Inc • Services-commercial physical & biological research
The undersigned hereby agree that the Statement on this Schedule 13G/A, dated February 14, 2003, (the "Schedule 13G/A"), with respect to the Common Stock, par value $0.0001 per share, of Pharmacopeia, Inc. is filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities and Exchange Act of 1934, as amended, and that this Agreement shall be included as an Exhibit to this Schedule 13G/A. Each of the undersigned agrees to be responsible for the timely filing of the Schedule 13G/A, and for the completeness and accuracy of the information concerning itself contained therein. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
EX-2.1Share Acquisition Agreement • March 9th, 2000 • Pharmacopeia Inc • Services-commercial physical & biological research
LEASEPharmacopeia Inc • November 12th, 1996 • Services-commercial physical & biological research
AMENDMENT TO NONEXCLUSIVE LICENSE AGREEMENTNonexclusive License Agreement • October 2nd, 2001 • Pharmacopeia Inc • Services-commercial physical & biological research • Washington
STANDARD INDUSTRIAL/COMMERCIAL MULTI-TENANT LEASE MODIFIED NETAccelrys, Inc. • March 15th, 2011 • Services-prepackaged software
BASIC LEASE PROVISIONS ----------------------Basic Lease • November 13th, 1998 • Pharmacopeia Inc • Services-commercial physical & biological research • California
VOTING AGREEMENTVoting Agreement • April 6th, 2010 • Accelrys, Inc. • Services-prepackaged software • Delaware
This Voting Agreement (“Voting Agreement”) is entered into as of April 5, 2010, by and between Accelrys, Inc., a Delaware corporation (“Parent”), and _______ (“Stockholder”).
EMPLOYMENT AGREEMENTEmployment Agreement • April 22nd, 2010 • Accelrys, Inc. • Services-prepackaged software • California
This EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into as of the Effective Date, as defined below, by and between Accelrys, Inc., a Delaware corporation (hereinafter, the “Company”), and Todd Johnson, an individual (hereinafter, “Executive”).
LEASE AGREEMENTLease Agreement • November 10th, 2003 • Pharmacopeia Inc • Services-commercial physical & biological research • New Jersey
AGREEMENT, made August 20,2003, between Eastpark at 8A, 1000 Eastpark Blvd., Cranbury, New Jersey 08512, “Landlord”; and Pharmacopeia, Inc., 3000 Eastpark Boulevard, Cranbury, NJ 08512, “Tenant”.
RESEARCH AGREEMENTResearch Agreement • March 11th, 1997 • Pharmacopeia Inc • Services-commercial physical & biological research • New York
TRANSITION SERVICES AGREEMENTTransition Services Agreement • May 3rd, 2004 • Pharmacopeia Inc • Services-prepackaged software • Delaware
THIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is dated as of this 30th day of April, 2004, by and between PHARMACOPEIA, INC., a Delaware corporation (“Pharmacopeia”), and ACCELRYS INC., a Delaware corporation and a wholly owned subsidiary of Pharmacopeia (Pharmacopeia and Accelrys Inc. are referred to herein collectively as “Accelrys”), on the one hand, and PHARMACOPEIA DRUG DISCOVERY, INC., a Delaware corporation (“PDD”), on the other hand. Each of Accelrys and PDD is sometimes hereinafter referred to as a “Party” and together as the “Parties.”
